InsiderClue
← All stocks

Guardant Health, Inc.

GH Net selling
CIK 0001576280 #681 in the set updated 21 Sep 2026
Bought (12 mo)
$78.46K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$173.91M
$34.69M on a plan · $85.98M straight out of an exercise
Sold at will
$53.23M
49 of 144 sales
Net
−$173.83M
−$53.16M against sales at will

By person

18 insiders · 145 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Talasaz AmirAli
Co-Chief Executive Officer
—
$84.25M (28) scheduled
−$84.25M
2,050,957
1.53%
$358.92M
−20.2%
Eltoukhy Helmy
Co-Chief Executive Officer
—
$22.03M (9)
−$22.03M
4,003,660
2.98%
$700.64M
−6.9%
Freeman Chris
Chief Commercial Officer
—
$16.92M (16) scheduled
−$16.92M
65,374
0.0487%
$11.44M
+136.1%
Monroe Terilyn J.
Chief People Officer
—
$15.95M (19) scheduled
−$15.95M
22,979
0.0171%
$4.02M
+1,198%
Bell Michael Brian
Chief Financial Officer
—
$8.81M (14) scheduled
−$8.81M
51,816
0.0386%
$9.07M
+158.7%
CLARK IAN T
Director
—
$6.06M (6) scheduled
−$6.06M
2,975
0.0022%
$520.63K
−81.0%
Kalia Kumud
Chief Information Officer
$78.46K (1)
$5.91M (8) scheduled
−$5.83M
39,794
0.0297%
$6.96M
+73.3%
Chudova Darya
Chief Technology Officer
—
$4.36M (4)
−$4.36M
125,115
0.0932%
$21.90M
+39.8%
Saia John G.
Chief Legal Officer
—
$4.25M (6) scheduled
−$4.25M
38,991
0.0291%
$6.82M
+33.4%
Krognes Steve E.
Director
—
$2.40M (5)
−$2.40M
7,906
0.0059%
$1.38M
−17.7%
Joyce Meghan V.
Director
—
$1.27M (4) scheduled
−$1.27M
15,386
0.0115%
$2.69M
+47.8%
Hidalgo Medina Manuel
Director
—
$936.15K (11) scheduled
−$936.15K
4,788
0.0036%
$837.90K
—
Tariq Musa
Director
—
$410.71K (11) scheduled
−$410.71K
11,449
0.0085%
$2.00M
+154.6%
POTTER MYRTLE S
Director
—
$205.83K (2) scheduled
−$205.83K
20,971
0.0156%
$3.67M
+55.2%
Azar Alex M II
Director
—
$144.55K (1) scheduled
−$144.55K
825
0.0006%
$144.38K
—
EAGLE CRAIG
Chief Medical Officer
—
—
—
72,001
0.0537%
$12.60M
+275.3%
Gadde Vijaya
Director
—
—
—
28,517
0.0213%
$4.99M
+61.7%
MIGNONE ROBERTO
Director
—
—
—
10,010
0.0075%
$1.75M
—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 168
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 39
Sales straight out of an exercise 56
Sales at will 49
Transactions with no price 0
Shares from compensation/vesting 3,230,329
History held since 11 Oct 2018